162 related articles for article (PubMed ID: 11277342)
1. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy.
Sato A; Saruta T
J Int Med Res; 2001; 29(1):13-21. PubMed ID: 11277342
[TBL] [Abstract][Full Text] [Related]
2. Plasma aldosterone concentrations are not related to the degree of angiotensin-converting enzyme inhibition in essential hypertensive patients.
Sato A; Suzuki Y; Shibata H; Saruta T
Hypertens Res; 2000 Jan; 23(1):25-31. PubMed ID: 10737132
[TBL] [Abstract][Full Text] [Related]
3. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
Sato A; Suzuki Y; Saruta T
Hypertens Res; 1999 Mar; 22(1):17-22. PubMed ID: 10221346
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
[TBL] [Abstract][Full Text] [Related]
5. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
du Cailar G; Fesler P; Ribstein J; Mimran A
Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
[TBL] [Abstract][Full Text] [Related]
6. Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension.
Sato A; Hayashi M; Saruta T
Hypertens Res; 2002 Nov; 25(6):837-42. PubMed ID: 12484506
[TBL] [Abstract][Full Text] [Related]
7. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients.
Sasaguri M; Noda K; Tashiro E; Notomo J; Tsuji E; Koga M; Arakawa K
Hypertens Res; 2000 Jul; 23(4):317-22. PubMed ID: 10912767
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
Steele JL; Henik RA; Stepien RL
Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
[TBL] [Abstract][Full Text] [Related]
9. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
[TBL] [Abstract][Full Text] [Related]
10. High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients.
Sato A; Takane H; Saruta T
Hypertens Res; 2001 Mar; 24(2):99-104. PubMed ID: 11325081
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the incidence of imidapril and enalapril induced cough.
Boonyapisit W; Tresukosol D
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S48-53. PubMed ID: 20364557
[TBL] [Abstract][Full Text] [Related]
12. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
Hosoya K; Ishimitsu T
Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
[TBL] [Abstract][Full Text] [Related]
14. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
Ovchinnikov AG; Serbul VM; Ageev FT
Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
[TBL] [Abstract][Full Text] [Related]
15. Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril.
Ciulla MM; Paliotti R; Esposito A; Cuspidi C; Muiesan ML; Rosei EA; Magrini F; Zanchetti A
J Hypertens; 2009 Mar; 27(3):626-32. PubMed ID: 19262230
[TBL] [Abstract][Full Text] [Related]
16. Effects of imidapril on left ventricular mass in chronic hemodialysis patients.
Matsumoto N; Ishimitsu T; Okamura A; Seta H; Takahashi M; Matsuoka H
Hypertens Res; 2006 Apr; 29(4):253-60. PubMed ID: 16778332
[TBL] [Abstract][Full Text] [Related]
17. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
[TBL] [Abstract][Full Text] [Related]
19. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
